Walking the Talk: Doing Science with Perimenopausal Women and their Health Care Providers

Authors

Jerilynn C. Prior, Centre for Menstrual Cycle and Ovulation Research, Division of Endocrinology, Department of Internal Medicine, University of British Columbia, Vancouver, B.C. CanadaFollow
Christine L. Hitchcock, Centre for Menstrual Cycle and Ovulation Research, Division of Endocrinology, Department of Internal Medicine, University of British Columbia, Vancouver, B.C. CanadaFollow
Poornima Sathi
Marg Tighe

Disciplines

Endocrinology, Diabetes, and Metabolism

Abstract

Perimenopausal high estrogen levels amplify the social stress of changing reproductive status in a culture that places value on women’s youth and beauty. As it was realized that progesterone physiologically counterbalances the effects of estrogen, it would be better to use progesterone, rather than estrogen for appropriate therapy of perimenopause. Based on this new knowledge was designed a three-arm study project comparing the recommended therapy, low dose OC (oral contraceptives) against progesterone therapy. In the pilot project cooperated Health Care Providers (HCP), by whose help was assembled eleven domains, which perimenopausal women find the most problematic. These HCP were also providing consultations for women with these problems, what gave to the women a good chance of self-analyses of their experience, and to HCP knowledge that the participation with their patients can bring something new into their practice.

Recommended Citation

Prior, Jerilynn C.; Hitchcock, Christine L.; Sathi, Poornima; and Tighe, Marg (2007) "Walking the Talk: Doing Science with Perimenopausal Women and their Health Care Providers," Journal of Interdisciplinary Feminist Thought: Vol. 2: Iss. 1, Article 6.
Available at: https://digitalcommons.salve.edu/jift/vol2/iss1/6